Fierce BiotechBiogen gets mixed decision at FDA AdComm on failed ALS drug as experts back conditional, not full, approvalMar 23, 2023more_vert
ReutersFDA staff says safety issues with Biogen's ALS drug to not prevent approvalMar 21, 2023Bhanvi SatijaBy Bhanvi Satijamore_vert